Autoimmune hemolytic anemias (AIHAs) are rare and heterogeneous disorders
characterized by the destruction of red blood cells through warm or cold antibodies. There is …

Several hemolytic markers are available to guide the differential diagnosis and to monitor
treatment of hemolytic conditions. They include increased reticulocytes, an indicator of …

Background Primary immunodeficiencies (PIDs) are inherited diseases associated with a
considerable increase in susceptibility to infections. It is known that PIDs can also …

The article presents guidelines for the diagnosis and management of patients with primary
autoimmune haemolytic anaemia (AIHA). Topics discussed include diagnostic approach to …

The clinical outcome, response to treatment, and occurrence of acute complications were
retrospectively investigated in 308 primary autoimmune hemolytic anemia (AIHA) cases and …

Autoimmune hemolytic anemia (AIHA) is a relatively uncommon disorder caused by
autoantibodies directed against self red blood cells. It can be idiopathic or secondary, and …

Autoimmune hemolytic anemia (AIHA) is an uncommon entity that presents diagnostic,
prognostic, and therapeutic dilemmas despite being a well-recognized entity for over 150 …

Autoimmune hemolytic anemia (AIHA) is caused by the increased destruction of red blood
cells (RBCs) by anti-RBC autoantibodies with or without complement activation. RBC …

Evans syndrome (ES) is a rare severe autoimmune disorder characterized by the
combination of autoimmune hemolytic anemia and immune thrombocytopenia. In most …

Primary immune regulatory disorders (PIRD) are associated with autoimmunity,
autoinflammation and/or dysregulation of lymphocyte homeostasis. Autoimmune …